US Stock MarketDetailed Quotes

LIXT Lixte Biotechnology

Watchlist
  • 2.0200
  • -0.0900-4.27%
Close Nov 1 16:00 ET
  • 1.9732
  • -0.0468-2.32%
Post 18:33 ET
4.54MMarket Cap-1174P/E (TTM)

Lixte Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
-26.52%-1.17M
Net income from continuing operations
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
31.07%-1.02M
-7.89%-1.67M
17.46%-1.37M
6.18%-6.31M
19.61%-1.63M
-19.32%-1.48M
Change In working capital
-71.26%61.19K
143.82%79.17K
-86.71%20.56K
-30.40%26.08K
59.34%-37.74K
395.50%212.91K
-164.04%-180.69K
1,251.39%154.76K
-72.78%37.47K
-155.09%-92.81K
-Change in prepaid assets
70.12%102.56K
-94.50%-69.81K
59.15%102.46K
-52.52%24.92K
74.78%53.14K
47.02%60.28K
39.70%-35.89K
158.36%64.38K
-31.87%52.49K
-68.85%30.41K
-Change in payables and accrued expense
-180.68%-115.28K
1,566.31%89.93K
-3,291.37%-73.98K
17.36%-65.38K
-122.56%-145.36K
4,340.55%142.9K
-104.27%-6.13K
-93.50%2.32K
-866.25%-79.12K
-222.78%-65.31K
-Change in other working capital
659.63%73.91K
142.58%59.05K
-109.00%-7.92K
3.81%66.54K
194.09%54.48K
108.37%9.73K
-169.98%-138.67K
43.90%88.06K
27.48%64.09K
69.07%-57.9K
Cash from discontinued investing activities
Operating cash flow
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
-26.52%-1.17M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
0
0
-38.86%3.14M
0
3.14M
0
157.59%6.28K
31.92%5.14M
0
0
Net common stock issuance
----
----
-38.98%3.14M
--0
----
----
----
39.34%5.14M
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--6.32K
--0
--41
--0
--6.28K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
-38.86%3.14M
--0
--3.14M
--0
157.59%6.28K
31.92%5.14M
--0
--0
Net cash flow
Beginning cash position
-16.49%3.41M
-21.48%4.2M
10.98%5.35M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
-4.84%4.82M
10.09%6.56M
13.79%7.74M
Current changes in cash
30.32%-819.04K
37.62%-789.23K
-317.11%-1.15M
25.35%-902.12K
286.78%2.19M
-129.70%-1.18M
-20.94%-1.27M
315.72%529.65K
-6.30%-1.21M
-40.11%-1.17M
End cash Position
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-22.19%5.11M
-62.34%2.91M
8.22%4.09M
10.98%5.35M
10.98%5.35M
10.09%6.56M
Free cash flow
30.32%-819.04K
37.92%-789.23K
6.91%-4.29M
25.35%-902.12K
19.55%-944.39K
1.58%-1.18M
-22.83%-1.27M
-11.32%-4.61M
-5.37%-1.21M
-26.52%-1.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M-26.52%-1.17M
Net income from continuing operations 39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M31.07%-1.02M-7.89%-1.67M17.46%-1.37M6.18%-6.31M19.61%-1.63M-19.32%-1.48M
Change In working capital -71.26%61.19K143.82%79.17K-86.71%20.56K-30.40%26.08K59.34%-37.74K395.50%212.91K-164.04%-180.69K1,251.39%154.76K-72.78%37.47K-155.09%-92.81K
-Change in prepaid assets 70.12%102.56K-94.50%-69.81K59.15%102.46K-52.52%24.92K74.78%53.14K47.02%60.28K39.70%-35.89K158.36%64.38K-31.87%52.49K-68.85%30.41K
-Change in payables and accrued expense -180.68%-115.28K1,566.31%89.93K-3,291.37%-73.98K17.36%-65.38K-122.56%-145.36K4,340.55%142.9K-104.27%-6.13K-93.50%2.32K-866.25%-79.12K-222.78%-65.31K
-Change in other working capital 659.63%73.91K142.58%59.05K-109.00%-7.92K3.81%66.54K194.09%54.48K108.37%9.73K-169.98%-138.67K43.90%88.06K27.48%64.09K69.07%-57.9K
Cash from discontinued investing activities
Operating cash flow 30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M-26.52%-1.17M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 00-38.86%3.14M03.14M0157.59%6.28K31.92%5.14M00
Net common stock issuance ---------38.98%3.14M--0------------39.34%5.14M--0--0
Proceeds from stock option exercised by employees --0--0--6.32K--0--41--0--6.28K--0--0--0
Cash from discontinued financing activities
Financing cash flow --0--0-38.86%3.14M--0--3.14M--0157.59%6.28K31.92%5.14M--0--0
Net cash flow
Beginning cash position -16.49%3.41M-21.48%4.2M10.98%5.35M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M-4.84%4.82M10.09%6.56M13.79%7.74M
Current changes in cash 30.32%-819.04K37.62%-789.23K-317.11%-1.15M25.35%-902.12K286.78%2.19M-129.70%-1.18M-20.94%-1.27M315.72%529.65K-6.30%-1.21M-40.11%-1.17M
End cash Position -10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M-22.19%5.11M-62.34%2.91M8.22%4.09M10.98%5.35M10.98%5.35M10.09%6.56M
Free cash flow 30.32%-819.04K37.92%-789.23K6.91%-4.29M25.35%-902.12K19.55%-944.39K1.58%-1.18M-22.83%-1.27M-11.32%-4.61M-5.37%-1.21M-26.52%-1.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data